ALISON MCINTYRE: Open Payments
NPI 1093498941 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,912 in 172 payments from 24 companies in 2025. Trend: 2023 $756 · 2024 $4,796 · 2025 $4,912
Food & beverage: $4,714Education: $198
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 19 | $835 |
| ABBVIE INC. | 30 | $647 |
| Janssen Biotech, Inc. | 18 | $478 |
| Regeneron Healthcare Solutions, Inc. | 11 | $356 |
| Amgen Inc. | 10 | $310 |
| UCB, Inc. | 7 | $294 |
| Botanix SB Inc | 13 | $279 |
| GENZYME CORPORATION | 10 | $200 |
| Organon LLC | 4 | $187 |
| Galderma Laboratories, L.P. | 8 | $187 |
Products named: Zoryve, TREMFYA, DUPIXENT, SKYRIZI, OTEZLA, Bimzelx, SOFDRA, RINVOQ.
Industry payments across FL — which companies pay providers there.
